相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
Yu-Yun Shao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells
Li Ma et al.
ONCOTARGET (2015)
Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner
Irina Kiprianova et al.
NEOPLASIA (2015)
Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells
A. Rodriguez-Hernandez et al.
REDOX BIOLOGY (2015)
Clinical Impact of Chemotherapy-Related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System
Nazia Rashid et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2015)
Molecular Pathways: Epigenetic Modulation of Wnt-Glycogen Synthase Kinase-3 Signaling to Target Human Cancer Stem Cells
Yannick D. Benoit et al.
CLINICAL CANCER RESEARCH (2014)
Do mantle cell lymphomas have an 'Achilles heel'?
Nakhle Saba et al.
CURRENT OPINION IN HEMATOLOGY (2014)
NF-κB in Cellular Senescence and Cancer Treatment
Hua Jing et al.
MOLECULES AND CELLS (2014)
Mesenchymal Stem Cells Promote Liver Regeneration and Prolong Survival in Small-For-Size Liver Grafts: Involvement of C-Jun N-Terminal Kinase, Cyclin D1, and NF-κB
Weijie Wang et al.
PLOS ONE (2014)
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
Man-Hsin Hung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/β-Catenin Signaling Pathway
Deepak Bhatia et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Epidemiology of Hepatocellular Carcinoma Consider the Population
Sahil Mittal et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells
W-T Tai et al.
CELL DEATH & DISEASE (2013)
Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
Romain Coriat et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Quercetin Inhibits Diethylnitrosamine-Induced Hepatic Preneoplastic Lesions in Rats
C. Gupta et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2011)
Loss of Metallothionein Predisposes Mice to Diethylnitrosamine-Induced Hepatocarcinogenesis by Activating NF-κB Target Genes
Sarmila Majumder et al.
CANCER RESEARCH (2010)
Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model
Yue-Fang Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas
Fan Yang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Altered beta-Catenin Accumulation in Hepatocellular Carcinomas of Diethylnitrosamine-Exposed Rhesus Macaques
Bih-Rong Wei et al.
TOXICOLOGIC PATHOLOGY (2008)
The β-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy
Xin Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3
K Leslie et al.
CANCER RESEARCH (2006)
Cyclin D1 over-expression correlates with β-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3β and ERK1/2 in mouse hepatic carcinogenesis
J Gotoh et al.
CARCINOGENESIS (2003)
分享论文
